Novel Therapies That May Cure Chronic Hepatitis B Virus
- PMID: 34593159
- DOI: 10.1016/j.cld.2021.07.001
Novel Therapies That May Cure Chronic Hepatitis B Virus
Abstract
The hepatitis B virus (HBV) is a member of the Hepadnaviridae family, which includes small DNA enveloped viruses that infect primates, rodents, and birds and is the causative factor of chronic hepatitis B. A common feature of all these viruses is their great specificity by species and cell type, as well as a peculiar genomic and replication organization similar to that of retroviruses. The HBV virion consists of an external lipid envelope and an internal icosahedral protein capsid containing the viral genome and a DNA polymerase, which also functions as a reverse transcriptase.
Keywords: Hepatitis B virus; Immunomodulators; Inhibitors of viral replication; New anti-HBV therapy; Viral antigen inbibitors; Viral replication Inhibitors; Viral replication cycle; cccDNA.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest A. Loglio: speaker bureau for MYR Pharma. M. Viganò, speaker bureau for Gilead and Abbvie. P. Lampertico: advisor and speaker bureau for BMS, Roche, Gilead Sciences, GSK, MSD, Abbvie, Janssen, Arrowhead, Alnylam, Eiger, MYR Pharma, Antios, Aligos.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources